doxycycline · Galderma Labs Lp · NDA 050805
Oracea
Earliest generic entry, as listed
19 Dec 2027
Blocked by patent: US 7749532.
Listed patents · 1 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 7749532 | product, use U-1063 | 19 Dec 2027 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 050805 · 001 · RLD | capsule, oral | 40MG | 19 Dec 2027 |